Literature DB >> 32594028

Dopamine: an immune transmitter.

Sarah Thomas Broome1, Krystal Louangaphay1, Kevin A Keay2, Gian Marco Leggio3, Giuseppe Musumeci4, Alessandro Castorina5.   

Abstract

The dopaminergic system controls several vital central nervous system functions, including the control of movement, reward behaviors and cognition. Alterations of dopaminergic signaling are involved in the pathogenesis of neurodegenerative and psychiatric disorders, in particular Parkinson's disease, which are associated with a subtle and chronic inflammatory response. A substantial body of evidence has demonstrated the non-neuronal expression of dopamine, its receptors and of the machinery that governs synthesis, secretion and storage of dopamine across several immune cell types. This review aims to summarize current knowledge on the role and expression of dopamine in immune cells. One of the goals is to decipher the complex mechanisms through which these cell types respond to dopamine, in order to address the impact this has on neurodegenerative and psychiatric pathologies such as Parkinson's disease. A further aim is to illustrate the gaps in our understanding of the physiological roles of dopamine to encourage more targeted research focused on understanding the consequences of aberrant dopamine production on immune regulation. These highlights may prompt scientists in the field to consider alternative functions of this important neurotransmitter when targeting neuroinflammatory/neurodegenerative pathologies.

Entities:  

Keywords:  D3R; Parkinson’s disease; astrocyte; autoimmune disease; dopamine; dopamine receptors; immune transmitter; microglia; multiple sclerosis; neuroinflammation

Year:  2020        PMID: 32594028     DOI: 10.4103/1673-5374.284976

Source DB:  PubMed          Journal:  Neural Regen Res        ISSN: 1673-5374            Impact factor:   5.135


  10 in total

Review 1.  Control of complex behavior by astrocytes and microglia.

Authors:  P I Ortinski; K J Reissner; J Turner; T A Anderson; A Scimemi
Journal:  Neurosci Biobehav Rev       Date:  2022-04-01       Impact factor: 9.052

2.  Modulation of Dopamine Receptors on Osteoblasts as a Possible Therapeutic Strategy for Inducing Bone Formation in Arthritis.

Authors:  Elena Schwendich; Laura Salinas Tejedor; Gernot Schmitz; Markus Rickert; Jürgen Steinmeyer; Stefan Rehart; Styliani Tsiami; Jürgen Braun; Xenofon Baraliakos; Jörg Reinders; Elena Neumann; Ulf Müller-Ladner; Silvia Capellino
Journal:  Cells       Date:  2022-05-11       Impact factor: 7.666

Review 3.  A "Drug-Dependent" Immune System Can Compromise Protection against Infection: The Relationships between Psychostimulants and HIV.

Authors:  María Amparo Assis; Pedro Gabriel Carranza; Emilio Ambrosio
Journal:  Viruses       Date:  2021-04-21       Impact factor: 5.048

4.  The Anxiolytic Drug Buspirone Prevents Rotenone-Induced Toxicity in a Mouse Model of Parkinson's Disease.

Authors:  Sarah Thomas Broome; Alessandro Castorina
Journal:  Int J Mol Sci       Date:  2022-02-06       Impact factor: 5.923

Review 5.  Immune and Nervous Systems Interaction in Endocrine Disruptors Toxicity: The Case of Atrazine.

Authors:  Valentina Galbiati; Erica Buoso; Roberta d'Emmanuele di Villa Bianca; Rosanna Di Paola; Fabiana Morroni; Giuseppe Nocentini; Marco Racchi; Barbara Viviani; Emanuela Corsini
Journal:  Front Toxicol       Date:  2021-03-10

6.  Lactobacillus plantarum-derived postbiotics prevent Salmonella-induced neurological dysfunctions by modulating gut-brain axis in mice.

Authors:  Yanping Wu; Yan Wang; Aixin Hu; Xin Shu; Wenxia Huang; Jinsong Liu; Baikui Wang; Ruiqiang Zhang; Min Yue; Caimei Yang
Journal:  Front Nutr       Date:  2022-07-28

Review 7.  Neuroendocrine regulations in tissue-specific immunity: From mechanism to applications in tumor.

Authors:  Si-Qing Liu; Bei Li; Juan-Juan Li; Si Sun; Sheng-Rong Sun; Qi Wu
Journal:  Front Cell Dev Biol       Date:  2022-08-22

Review 8.  Crosstalk between the Gut and Brain in Ischemic Stroke: Mechanistic Insights and Therapeutic Options.

Authors:  Wenjing Huang; Luwen Zhu; Wenjing Song; Mei Zhang; Lili Teng; Minmin Wu
Journal:  Mediators Inflamm       Date:  2022-10-11       Impact factor: 4.529

9.  Assessing the Anti-Inflammatory Activity of the Anxiolytic Drug Buspirone Using CRISPR-Cas9 Gene Editing in LPS-Stimulated BV-2 Microglial Cells.

Authors:  Sarah Thomas Broome; Teagan Fisher; Alen Faiz; Kevin A Keay; Giuseppe Musumeci; Ghaith Al-Badri; Alessandro Castorina
Journal:  Cells       Date:  2021-05-25       Impact factor: 6.600

Review 10.  Neuroprotection and Disease Modification by Astrocytes and Microglia in Parkinson Disease.

Authors:  Shinichi Takahashi; Kyoko Mashima
Journal:  Antioxidants (Basel)       Date:  2022-01-17
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.